- Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.
- Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.
- Trump-era tariffs may benefit AI stocks, while Google faces DOJ rulings and secures a default search engine deal with Apple.
- AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.
Paige, acquired by Tempus AI, has received FDA clearance, while AI stocks continue to benefit from onshoring and tariff trends.
2 reports, 2 independent
Updated Aug 30
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Paige, acquired by Tempus AI, has received FDA clearance, while AI stocks continue to benefit from onshoring and tariff trends.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Tempus AI, led by Eric Lefkofsky, is acquiring Paige to enhance its digital pathology datasets.Sub-event
Tempus AI's acquired Paige received FDA clearance, amidst AI stocks benefiting from tariffs.1 source
Keep exploring
Part of
AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.Also in this story
- A partnership has been established where Wix merchants gain access to the Alibaba sourcing marketplace, leveraging trends benefiting AI stocks.
- Raymond James maintained a 'Strong Buy' rating for AI stocks, citing benefits from tariffs and onshoring trends.
- AI stocks may benefit from Trump tariffs and onshoring, potentially benefiting Cognex Corporation.
- Kevin McAleenan became CEO of BigBear.ai, which is involved in advanced technology partnerships, amid AI stock benefits from tariffs.
The entities involved
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Tempus
biotechnology company based in Chicago, Illinois
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyTempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition Tempus AI, Inc. (NASDAQ:TEM) is one of the best Robinhood stocks to buy right now. On August 22, the company confirmed the
- BenzingaTempus AI Expands Into Digital Pathology With Paige Acquisition Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology.